What the Merck TV commercial - Day #20 With Shingles is about.
Merck's TV spot, 'Day #20 With Shingles', is a poignant reminder of the pain and discomfort that shingles can cause. The ad showcases a man in his 50s who is suffering from the virus, which is caused by the same virus that causes chickenpox.
As the ad progresses, we see the man struggling to go about his daily routine while dealing with the painful rash and blisters that shingles can cause. He mentions his difficulty sleeping and the need to avoid close contact with his family members to avoid spreading the virus to those who have not had chickenpox or received the shingles vaccine.
The ad also highlights the need for prevention, reminding viewers that the best way to avoid shingles is through vaccination. It mentions that a vaccine is available for those aged 50 and above, and encourages viewers to talk to their healthcare provider to learn more about shingles and the vaccine.
Overall, Merck's TV spot is a powerful reminder of the impact that shingles can have on an individual's life. It highlights the need for prevention and serves as an important call to action for those who may be at risk of contracting the virus.
Merck TV commercial - Day #20 With Shingles produced for
Merck
was first shown on television on June 12, 2016.
Frequently Asked Questions about merck tv spot, 'day #20 with shingles'
In this study, ZOSTAVAX, Merck's vaccine for the prevention of herpes zoster, commonly known as shingles, significantly reduced the risk of developing shingles by nearly 70 percent in adults ages 50 to 59, compared with placebo.
Everyone aged 70 to 79 is eligible for the shingles vaccine. Depending on the type of vaccine you have, you'll have either 1 dose or 2 doses (given between 6 and 12 months apart). Contact your GP surgery if you missed your vaccine.
CDC recommends two doses of recombinant zoster vaccine (RZV, Shingrix) to prevent shingles and related complications in adults 50 years and older. Shingrix is also recommended for adults 19 years and older who have weakened immune systems because of disease or therapy.
As of January 2023, manufacturer GSK reports the list price for the Shingrix vaccine as $366.82 or $183.41 per dose. If you don't have health insurance, your pharmacy may charge more than the list price for the vaccine. According to GoodRx, the average retail price per dose of Shingrix is about $213.
Shingles is a viral infection that causes a painful rash. Shingles can occur anywhere on your body. It typically looks like a single stripe of blisters that wraps around the left side or the right side of your torso. Shingles is caused by the varicella-zoster virus - the same virus that causes chickenpox.
Two vaccines are licensed and recommended to prevent shingles in the U.S.. Zoster vaccine live (ZVL, Zostavax) has been in use since 2006. Recombinant zoster vaccine (RZV, Shingrix), has been in use since 2017 and is recommended by ACIP as the preferred shingles vaccine.
Coverage varies state by state. Medicaid covers SHINGRIX for patients 50 years and older in two-thirds of states (those that expanded Medicaid under the Affordable Care Act). WHERE SHOULD I GET SHINGRIX?
Who Should Get Shingrix? Adults 50 years and older should get two doses of Shingrix, separated by 2 to 6 months. Adults 19 years and older who have or will have weakened immune systems because of disease or therapy should also get two doses of Shingrix.
Shingles is a painful, usually itchy, rash that develops on one side of the face or body. The rash consists of blisters that typically scab over in 7 to 10 days and fully clear up within 2 to 4 weeks.
What causes shingles? Shingles is caused by varicella zoster virus (VZV), the same virus that causes chickenpox. After a person recovers from chickenpox, the virus stays dormant (inactive) in the body. This virus can reactivate years later, causing shingles.
Adults 50 years and older should get two doses of Shingrix, separated by 2 to 6 months. Adults 19 years and older who have or will have weakened immune systems because of disease or therapy should also get two doses of Shingrix.
As of January 2023, manufacturer GSK reports the list price for the Shingrix vaccine as $366.82 or $183.41 per dose. If you don't have health insurance, your pharmacy may charge more than the list price for the vaccine. According to GoodRx, the average retail price per dose of Shingrix is about $213.